Organization
Wangxia Lv
1 clinical trial
Clinical trial
Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type Metastatic Colorectal Cancer: A Single-center, Prospective Phase Ib/II StudyStatus: Recruiting, Estimated PCD: 2025-03-01